Peptidream Inc. company information, Employees & Contact Information

PeptiDream, PDRadiopharma and Curium Group Enroll First Patient to Registrational Clinical Trial of Business Wire

Curium Group, PeptiDream and PDRadiopharma Enroll First GlobeNewswire

NorthStar Medical Radioisotopes and PDRadiopharma Announce Research and Development Agreement, Master Isotope Supply Agreement for Ac-225 and Contract Manufacturing and Master Services Agreement Yahoo Finance

National Cancer Center Japan and PeptiDream: New Radiopharmaceuticals for Renal Cell Carcinoma Business Wire

Novartis pays PeptiDream $180M as radiopharma big bang continues Fierce Biotech

Cu-PD-32766 in a patient with Clear Cell Renal Cell Carcinoma ncc.go.jp

PeptiDream announces license of Peptide Discovery Platform System (PDPS) technology to Novartis Drug Target Review

Fujitsu and PeptiDream Achieve Milestone in Joint Research for Peptide Drug Candidates with High-Speed, High-Precision Exploration Technology - Fujitsu Global Fujitsu Global

Novartis re-ups on PeptiDream’s macrocyclic peptide promise | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Novartis and PeptiDream expand peptide discovery deal Pharmaceutical Technology

Putting peptides on display Nature

Curium Announces Strategic Partnership with PeptiDream for Prostate Cancer Theranostics in Japan Yahoo Finance

Genentech sees more potential in peptides, signs $1B biobucks deal with PeptiDream Fierce Biotech

PeptiDream Announces Collaboration and License Agreement with Genentech for the Discovery and Development of Novel Peptide-Radioisotope Drug Conjugates Business Wire

PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis Business Wire

PeptiDream Announces Collaboration and License Agreement with MSD for the Discovery and Development of Novel Peptide Drug Conjugates Business Wire

PeptiDream Announces New Research and Collaboration Agreement with Lilly for the Discovery of Novel Peptide Drug Conjugates Business Wire

Fierce Pharma Asia—Novartis and BeiGene's PD-1 breakup; Genentech's PeptiDream deal; Biocon's new CEO Fierce Pharma

Genentech, PeptiDream Ink Potential $1B Radiopharma Deal BioSpace

PeptiDream: Opulent Dream Now A Reality Seeking Alpha

Novartis, Peptidream expand peptide discovery effort in $2.7B deal BioWorld MedTech

Biohaven Enrolls Phase 1a/1b Clinical Trial of BHV-1100, Lead Asset from its ARM™ (Antibody Recruiting Molecule) Platform, in Combination with NK Cell Therapy for the Treatment of Multiple Myeloma PR Newswire

Novartis, PeptiDream Ink Potential $2.7B Deal to Expand Radioligand Discovery Partnership BioSpace

Roche’s Genentech bets on radiopharmaceuticals in partnership with PeptiDream BioPharma Dive

Astellas notches another protein degrader pact with $21M upfront for PeptiDream Fierce Biotech

PeptiDream Announces New Peptide Drug Conjugate (“PDC”) Collaboration Agreement with Novartis NAI500

PeptiDream Announces Preclinical Results Demonstrating Efficacy of Oral Myostatin Inhibitors in Preventing Loss of Lean Mass Associated with Semaglutide Treatment BioSpace

Fierce Pharma Asia—Ono buys Deciphera for $2.4B; Novartis expands PeptiDream collab; WuXi Bio exits BIO 2024 Fierce Pharma

Lilly, Merck double down on peptide-targeted drug delivery, betting billions in biobucks on PeptiDream pacts Fierce Pharma

Novartis and PeptiDream expand peptide discovery collaboration in deal worth over $2.8bn PMLiVE

Another day, another billion-dollar deal for PeptiDream, this time with Alnylam Fierce Biotech

Takeda reveals potential $3.5B value of central nervous system deep dive with PeptiDream Fierce Biotech

Japan’s PeptiDream Bags $1.11B+ R&D Pact With Bayer BioSpace

J&J taps PeptiDream for metabolic, cardiovascular R&D help Fierce Biotech

Japanese pharma firm PeptiDream inks $3 B worth deals for novel peptide drug conjugates BioSpectrum Asia

Organization and Innovation u-tokyo.ac.jp